Table 4.
Pooled HRs and 95%CIs from the meta-analysis of DFS.
| Non-coding RNA | Model | No. of studies | No. of patients | HR (95%CI) | P-value | Heterogeneity (%) | (I2, P-value) |
|---|---|---|---|---|---|---|---|
| miR-499(rs3746444) | TT vs. CT+CC | 3 | 2,285 | 0.82 (0.37, 1.83) | 0.635 | 91.2 | < 0.001 |
| miR-146(rs2910164) | GG vs. GC+CC | 4 | 2,648 | 0.70 (0.51, 0.97) | 0.030 | 49.0 | 0.117 |
| miR-149(rs2292832) | CC vs. CT+TT | 3 | 2,285 | 0.86 (0.62, 1.20) | 0.385 | 63.5 | 0.065 |
| miR-196a2(rs11614913) | CC vs. CT+TT | 3 | 2,456 | 1.71 (1.02, 2.84) | 0.040 | 86.0 | 0.001 |
| CT+TT vs. CC | 2 | 644 | 0.51 (0.25, 1.05) | 0.069 | 56.2 | 0.131 |
DFS, disease-free survival; HR, hazard ratio; CI, confidence interval. Bolded values are expressed as values of statistical significance.